Abstract CT203: Fc-optimized anti-CD40 agonist antibody 2141-V11 for BCG-unresponsive non-muscle invasive bladder cancer: Updates on phase 1 study clinical outcomes and biological correlatives

Authors: Juan C. Osorio, Lucas Blanchard, Ning Yao, Syed M. Alam, Juan Angulo-Lozano, Karissa Whiting, Venkatraman E. Seshan, Timothy F. Donahue, Eugene K. Cha, Robert Smith, Guido Dalbagni, Morgan Tomberlin, Melissa McCarter, Eugene J. Pietzak, Jonathan E. Rosenberg, Jeffrey V. Ravetch, Bernard H. Bochner

Published: 2025-04-25

DOI: 10.1158/1538-7445.am2025-ct203

Source: Full article